Shikha Gupta/X
Oct 26, 2024, 15:56
Shikha Gupta: CDK4/6 inhibitors as a promising therapeutic approach in translocation RCC
Shikha Gupta, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“Excited to have shared our research on CDK4/6 inhibitors as a promising therapeutic approach in translocation renal cell carcinoma at ENA Symp 24.
We’re hopeful that our findings will pave the way for future clinical trials & provide new treatment avenues for tRCC patients.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 16:16
Feb 22, 2025, 16:04
Feb 22, 2025, 16:00
Feb 22, 2025, 15:54
Feb 22, 2025, 15:48
Feb 22, 2025, 15:33
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10